$28.35 -$0.62 (-2.1%)

04:30 PM EST on 01/24/20

Editas Medicine (NASDAQ:EDIT)

CAPS Rating: 4 out of 5

Current Price $28.35 Mkt Cap $1.4B
Open $29.31 P/E Ratio 0.00
Prev. Close $28.35 Div. (Yield) $0.00 (0.0%)
Daily Range $27.90 - $29.35 Volume 703,783
52-Wk Range $27.90 - $34.37 Avg. Daily Vol. 890,954

Caps

How do you think NASDAQ:EDIT will perform against the market?

Add Stock to CAPS Watchlist

All Players

235 Outperform
8 Underperform
 

All-Star Players

83 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EDIT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

rhallbick (80.39)
Submitted April 15, 2018

Editas Medicine (NASDAQ: EDIT) is a biotech specializing in CRISPR-Cas9 research and development. CRISPR has promise for the treatment of patients with genetically defined diseases by correcting their disease?causing genes.CRISPR is an acronym for… More

btechrisk11 (< 20)
Submitted April 15, 2018

Still a lot to learn for CRISPR technology to translate to clinic safely. CRISPR can be fairly selective but there was a recent journal article suggesting many people have antibodies/immune responses against some of the CRISPR elements.

NASDAQ:EDIT VS S&P 500 (SPY)

NASDAQ:EDIT Summary

Fools bullish on NASDAQ:EDIT are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about EDIT.

Recs

0
Member Avatar hmui (53.60) Submitted: 1/19/2020 11:22:49 AM : Outperform Start Price: $30.00 NASDAQ:EDIT Score: -4.40

Customized medicine in the treatment of the future.

Recs

0
Member Avatar SurfingCabarete (36.08) Submitted: 7/9/2019 12:17:57 PM : Outperform Start Price: $23.84 NASDAQ:EDIT Score: +8.12

bet on gene editing

Recs

0
Member Avatar WilliamEbonics (65.97) Submitted: 5/20/2019 5:28:14 PM : Underperform Start Price: $22.17 NASDAQ:EDIT Score: -12.84

The Stock continues a downward drift, while money also continues to exit the stock over an extended period of time.

Leaderboard

Find the members with the highest scoring picks in EDIT.

Score Leader

PAGEBOY73

PAGEBOY73 (99.14) Score: +120.59

The Score Leader is the player with the highest score across all their picks in EDIT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
SeriousK 29.23 3/9/2016 Underperform 5Y $42.70 -33.61% +64.94% +98.54 0 Comment
TimeToBuy 86.49 3/10/2016 Underperform 5Y $32.50 -12.77% +64.44% +77.21 0 Comment
nobody2013 < 20 3/10/2016 Underperform NS $26.79 +5.82% +65.84% +60.02 1 Comment
freemarketmike < 20 6/7/2017 Outperform 5Y $15.43 +83.70% +35.02% +48.68 1 Comment
CMFMLove 46.10 6/13/2017 Outperform 5Y $16.00 +77.19% +34.77% +42.41 1 Comment
btechrisk11 < 20 4/16/2018 Underperform 3Y $34.93 -18.84% +23.15% +41.99 1 Comment
WoollyWombat < 20 9/16/2016 Outperform 5Y $14.48 +95.79% +54.12% +41.67 0 Comment
Playa14 < 20 6/9/2017 Outperform 5Y $16.08 +76.31% +34.71% +41.59 0 Comment
FunesDMemorious 95.54 10/26/2016 Outperform 5Y $14.55 +94.85% +54.22% +40.62 0 Comment
portefeuille2 98.87 9/22/2016 Outperform 5Y $14.87 +90.65% +51.55% +39.10 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EDIT.